Six predictors (postmenopausal status, metaplastic breast cancer,≥pT3 staging,≥pN1 staging,sTIL intermediate/high expression, and Her2 [1+]) were used to construct the predictive model of rapid relapse in TNBC patients (Figure 2). Here, ERBB2 is linked to metaplastic breast carcinoma.